CTOs on the Move

Pernix Therapeutics Holdings, Inc.

www.pernixtx.com

 
Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, and development of branded pharmaceutical products. The Company markets a portfolio of branded products, including: TREXIMET®, SILENOR®, a non-narcotic product indicated for the treatment of insomnia characterized by difficulties with sleep maintenance, KHEDEZLA™, as well as CEDAX®, an antibiotic for middle ear infections. The Company promotes its branded products to physicians through its Pernix sales force and distributes its generic portfolio through its wholly owned subsidiaries, Cypress Pharmaceuticals and Macoven Pharmaceuticals. Founded in 1996, the Company is based in Morristown, New Jersey.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.pernixtx.com
  • 10 N Park Pl Ste 201
    Morristown, NJ USA 07960
  • Phone: 800.793.2145

Executives

Name Title Contact Details

Similar Companies

Greater Nashua Mental Health

Greater Nashua Mental Health believes in empowering people to lead full and satisfying lives through effective treatment and support.

Viking Therapeutics

Novel therapeutics for metabolic and endocrine disorders

Runatek

At Runatek, were ending the Opioid Crisis with innovative technology

ABL Medical

ABL Medical, LLC

HEXO Corporation

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.